Literature DB >> 3030626

Levels of glycerate 2,3-P2, 2,3-bisphosphoglycerate synthase and 2,3-bisphosphoglycerate phosphatase activities in rat tissues. A method to quantify blood contamination of tissue extracts.

A Tauler, J Gil, R Bartrons, J Carreras.   

Abstract

The levels of glycerate 2,3-P2 and of 2,3-bisphosphoglycerate synthase and 2,3-bisphosphoglycerate phosphatase activities have been determined in isolated rat hepatocytes and adipocytes and in perfused rat tissues to discard blood contamination. The values obtained are much lower than those previously reported, ranging 0.50-40 nmol/g tissue. No relationship appears to exist between glycerate 2,3-P2 concentration and the levels of the enzymatic activities involved in glycerate 2,3-P2 metabolism. Assay of glycerate 2,3-P2 in tissue extracts constitute a very useful way to quantify blood contamination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030626     DOI: 10.1016/0305-0491(87)90167-2

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  4 in total

1.  Masses of inositol phosphates in resting and tetanically stimulated vertebrate skeletal muscles.

Authors:  G W Mayr; R Thieleczek
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

2.  Phosphorylation of adenosine in anoxic hepatocytes by an exchange reaction catalysed by adenosine kinase.

Authors:  F Bontemps; M Mimouni; G Van den Berghe
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

3.  Dephosphorylation of 2,3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt.

Authors:  Jaiesoon Cho; Jason S King; Xun Qian; Adrian J Harwood; Stephen B Shears
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

Review 4.  Fructose 2,6-Bisphosphate in Cancer Cell Metabolism.

Authors:  Ramon Bartrons; Helga Simon-Molas; Ana Rodríguez-García; Esther Castaño; Àurea Navarro-Sabaté; Anna Manzano; Ubaldo E Martinez-Outschoorn
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.